The agreement grants Lupin the right to introduce Vonoprazan, an innovative treatment for Acid Peptic Disorders (APD), which include Gastroesophageal Reflux Disease (GERD) and Peptic Ulcer Disease (PUD)
Read More
The product, available in 1 mg/4 mL (0.25 mg/mL) single-dose vials and 2.5 mg/10 mL (0.25 mg/mL) multiple-dose vials, is a generic version of Bumex Injection (0.25 mg/mL) by Validus Pharmaceuticals, LLC
Read More
This solution is used for relieving eye redness caused by minor irritations, providing a cost-effective alternative for consumers
Read More
This product is a generic version of AbbVie Inc.'s Pred Forte Ophthalmic Suspension, 1%
Read More
Cyclosporine Ophthalmic Nanoemulsion employs unique nanoparticle technology to increase tear production in patients with keratoconjunctivitis sicca-related ocular inflammatory disease, offering faster symptom relief for those with suppressed tear formation
Read More
The facility has been granted a Voluntary Action Indicated (VAI) status following an inspection that took place from May 7 to May 17, 2024
Read More
